Sleep Medicine News

Parents commonly reported sleep concerns that persisted with age for children with early-life epilepsies, according to study results published in Pediatric Neurology.

Cognitive behavioral therapy for insomnia may help prevent major depression among older adults with insomnia disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.

Sleep-related hypoxia may be a risk factor for detrimental COVID-19 outcomes, according to results of a case-control study published in JAMA Network Open.

Older adults frequently used medication to treat sleep difficulties, according to study results presented at Psych Congress.

Preoperative presence of REM sleep behavior disorder in patients with Parkinson’s disease did not correlate with different clinical outcome 1 year after subthalamic deep brain stimulation, according to a study published in Neurology.

Prescriptions for Z-hypnotics, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and benzodiazepines have increased during the COVID-19 pandemic.

LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.

In patients with moderate to severe obstructive sleep apnea, carbonic anhydrase inhibition with sulthiame was safe and improved outcomes in the short term, researchers reported at the European Respiratory Society International Congress.

Individuals with migraine had much poorer subjective sleep quality and altered sleep architecture vs. healthy individuals, according to results of a meta-analysis published in Neurology.

A new clinical trial is underway to evaluate the long-term effectiveness of inspiratory muscle training to reduce blood pressure and improve cardiovascular health in adults with obstructive sleep apnea.